Elsevier

Biochemical Pharmacology

Volume 37, Issue 4, 15 February 1988, Pages 665-671
Biochemical Pharmacology

Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes

https://doi.org/10.1016/0006-2952(88)90140-2Get rights and content

Abstract

The glucuronidation kinetics of 4-methylumbelliferone (4MU) and 1-naphthol (1NP) have been investigated in human liver microsomes to determine the validity of using these compounds as probes for specific UDP-glucuronosyltransferase (GT) activities in human liver. 4MU glucuronidation followed Michaelis-Menten kinetics, whereas 1NP glucuronidation kinetics were biphasic. Cross inhibition studies were performed with 4MU and 1NP to determine the relationship between 4MU glucuronidation and the two phases of 1NP glucuronidation. 4MU glucuronidation was competitively inhibited by 1NP but 4MU inhibited only the high affinity component of 1NP glucuronidation. There was good agreement between the apparent Km values for 4MU and the high affinity component of 1NP glucuronidation and their respective apparent Ki values determined in the cross inhibition studies. These data suggest that the same form(s) of human liver GT is involved in 4MU glucuronidation and the high affinity component of 1NP glucuronidation.

A number of compounds known to be specific substrates for purified rat liver GTs were screened for inhibitory effects on 4MU glucuronidation in human liver microsomes. 4-Nitrophenol, 2-aminophenol and androsterone inhibited 4MU glucuronidation whereas bilirubin, chloramphenicol, digitoxigenin monodigitoxoside, morphine, oestrone and testosterone had no effect. 4-Nitrophenol and 2-aminophenol were competitive inhibitors of 4MU glucuronidation but the inhibition of 4MU glucuronidation by androsterone followed atypical kinetics. Overall, the substrate specificity of the human liver 4MU/high affinity 1NP-GT activity appears to be broadly similar to that of the 3-methylcholanthrene inducible rat hepatic microsomal GT.

References (31)

  • W. Lilienblum et al.

    Biochem. Pharmac.

    (1982)
  • B. Burchell

    FEBS Lett.

    (1980)
  • C.N. Falany et al.

    Archs Biochem. Biophys.

    (1983)
  • P.I. MacKenzie

    J. biol. Chem.

    (1986)
  • P.I. MacKenzie

    J. biol. Chem.

    (1986)
  • T. Iyanagi et al.

    J. biol. Chem.

    (1986)
  • P.I. MacKenzie et al.

    Biochem. Pharmac.

    (1985)
  • O.H. Lowry et al.

    J. biol. Chem.

    (1951)
  • G.J. Wishart

    Biochem. J.

    (1978)
  • G.J. Wishart

    Biochem. J.

    (1984)
  • J.B. Watkins et al.

    Drug Metab. Disp.

    (1985)
  • K.W. Bock et al.

    Eur. J. Biochem.

    (1979)
  • P.J. Weatherill et al.

    Biochem. J.

    (1980)
  • L. von Meyernick et al.

    Drug. Metab. Disp.

    (1985)
  • J. Roy Chowdhury et al.

    Biochem. J.

    (1986)
  • Cited by (52)

    • A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors

      2021, International Journal of Biological Macromolecules
      Citation Excerpt :

      By contrast, the approaches for assessing drug interaction potentials mediated by human UGTs are rarely reported, owing to the lack of a good substrate(s) for the entire panel of important human UGTs [32–34]. Currently, 4-methylumbelliferone (4-MU), a non-specific UGT substrate, is frequently used as the broad-spectrum substrate of human UGTs for evaluating UGT-mediated drug interaction potentials [35]. However, UGT1A4 and 2B10 do not catalyze 4-MU glucuronidation, while UGT2B4 and 2B17 catalyze this reaction at very low rates.

    • Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7

      2007, Biochemical Pharmacology
      Citation Excerpt :

      Quantitative densitometry of glucuronides was based on a UDP-[U-14C]glucuronic acid standard curve (0.6 pmol to 6 pmol) using a scanning laser PhosphorImager and associated ImageQuant software (Molecular Dynamics Inc., CA, USA). The fluorescence assay of Miners et al. [35], with modifications [32], was used for quantification of 4-MU glucuronide formation by HKCM, UGT1A9 and UGT2B7. Preliminary studies established linearity of the reaction with respect to time and protein concentration, and less than 10% substrate consumption occurred during the course of the incubation.

    • Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes

      2006, Chemico-Biological Interactions
      Citation Excerpt :

      Several genetic polymorphisms with functional changes have been reported for the UGT1A6 gene. Ciotti et al. [26] originally identified two nonsynonymous single nucleotide polymorphisms (SNPs), UGT1A6*5 (541A > G, Thr181Ala) and UGT1A6*9 (552A > C, Arg184Ser), both of which were in high (but not complete) linkage disequilibrium with each other. These variations are located in the putative endoplasmic reticulum-localization signal [31].

    View all citing articles on Scopus
    View full text